Back to news

Dr. Reddy's Laboratories (RDY) Stock Falls on Q2 2027 Earnings

Investivoq EarningsTracker

Dr. Reddy's Laboratories Limited $RDY reported second-quarter 2027 results that showed lower revenue and sharply weaker profitability year over year. Total revenue came in at $903.9 million, down 8.8%, while gross profit fell 13.0% to $471.2 million.

Operating performance was under significant pressure, with operating profit dropping 71.6% to $132.2 million. Net income attributable to common shareholders declined 40.4% to $96.4 million, and diluted earnings per share fell to $0.12, down 33.3% from a year earlier.

Cash generation also weakened, with cash from operating activities falling 67.4% to $55.2 million. Capital spending on property, plant and equipment totaled $24.6 million, while cash and cash equivalents rose 31.2% to $138.6 million.

  • Revenue: $903.9 million, down 8.8% year over year
  • Operating profit: $132.2 million, down 71.6%
  • Net income: $96.4 million, down 40.4%
  • Cash from operations: $55.2 million, down 67.4%

The stock was down 2.69% in morning trading following the release.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Investivoq.

Investivoq Alerts
Receive RDY Data Alerts
Get market-moving data, filings, and signals for RDY in real time.
Sign Up

Dr. Reddy's Laboratories Limited Hedge Fund Activity

We have seen 97 institutional investors add shares of Dr. Reddy's Laboratories Limited stock to their portfolio, and 131 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. removed 9,340,290 shares (-51.8%) from their portfolio in Q3 2026, for an estimated $117,874,459
  • JPMORGAN CHASE & CO added 4,069,357 shares (+inf%) to their portfolio in Q2 2026, for an estimated $58,964,982
  • NUVEEN, LLC added 2,827,699 shares (+inf%) to their portfolio in Q2 2026, for an estimated $40,973,358
  • MORGAN STANLEY added 1,564,726 shares (+16.7%) to their portfolio in Q2 2026, for an estimated $22,672,879
  • SCHRODER INVESTMENT MANAGEMENT GROUP added 1,437,165 shares (+793.0%) to their portfolio in Q2 2026, for an estimated $20,824,520
  • ALLIANCEBERNSTEIN L.P. added 1,188,824 shares (+46.8%) to their portfolio in Q2 2026, for an estimated $17,226,059
  • BLACKROCK, INC. removed 1,001,385 shares (-8.6%) from their portfolio in Q2 2026, for an estimated $14,510,068

To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.